Cargando…
Clinical Efficacy of Modified Yiwei Shengyang Decoction Combined with FOLFOX4 Chemotherapy Regimen in the Treatment of Advanced Gastric Cancer and Its Effect on Tumor Marker Levels
OBJECTIVE: To study the clinical efficacy of modified Yiwei Shengyang decoction combined with FOLFOX4 chemotherapy regimen in the treatment of advanced gastric cancer and its effect on tumor marker levels. METHODS: A total of 106 patients with advanced gastric cancer who were treated in our hospital...
Autores principales: | Wu, Hongying, Miao, Xiaomei, Liu, Yan, Zhang, Shu, Li, Chaohui, Hao, Jie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098293/ https://www.ncbi.nlm.nih.gov/pubmed/35571732 http://dx.doi.org/10.1155/2022/6234032 |
Ejemplares similares
-
Shengyang Yiwei Decoction for the treatment of chronic gastritis: A protocol for a systematic review and meta-analysis
por: Xiong, Min, et al.
Publicado: (2020) -
Effect of modified ShengYangYiwei decoction on painless gastroscopy and gastrointestinal and immune function in gastric cancer patients
por: Mi, Sui-Cai, et al.
Publicado: (2023) -
Yiwei decoction promotes apoptosis of gastric cancer cells through spleen-derived exosomes
por: Chen, Yingzhi, et al.
Publicado: (2023) -
FOLFOX versus EOX as a neoadjuvant chemotherapy regimen for patients with advanced gastric cancer
por: CHEN, WENJUN, et al.
Publicado: (2014) -
The impact of Yiwei decoction on the LncRNA and CircRNA regulatory networks in premature ovarian insufficiency
por: Fan, Weisen, et al.
Publicado: (2023)